Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of piragrel sodium injection for acute ischemic stroke
ChiCTR2300072720Phase 3Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of piragrel sodium in ischemic stroke and brain infarction (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Proportion of subjects with modified Rankin Scale score 0 to 1. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
piragrel sodium
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR2300072720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072720.